Consulting Agreements in the Life Sciences Tools & Services Industry
48 Contracts & Agreements
- AbSci Corp (1 contract)
- Berkeley Lights, Inc. (1)
- BioNano Genomics, Inc (1)
- Cambrex Corporation (1)
- Charles River Laboratories (1)
- ChromaDex Corp. (1)
- CM Life Sciences II Inc. (1)
- CODEXIS INC (2)
- ECO SCIENCE SOLUTIONS, INC. (7)
- EVIO, INC. (1)
- HARVARD BIOSCIENCE INC (1)
- HighCape Capital Acquisition Corp. (1)
- IQVIA Holdings Inc. (1)
- Luminex Corporation (2)
- NanoString Technologies Inc (1)
- NEOGENOMICS INC (2)
- PerkinElmer (1)
- Pharma-Bio Serv, Inc. (9)
- Quanterix Corp (1)
- SeqLL, Inc. (2)
- Syneos Health (4)
- Thermo Fisher Scientific (1)
- VG Acquisition Corp. (3)
- Waters Corporation (2)
- Consulting Agreement between Atlantic International Corp. and Robert Machinist (SeqLL, Inc., Filed With SEC on June 25, 2024)
- Letter Agreement and Consulting Agreement, dated as of June 25, 2024, by and between the Company and Brianna Gerber (ChromaDex Corp., Filed With SEC on June 25, 2024)
- Consulting Agreement, dated as of May 23, 2024, by and between the Company and Kathy Hibbs (VG Acquisition Corp., Filed With SEC on May 24, 2024)
- Transition, Separation and Consulting Agreement dated as of August 11, 2023, by and between Christopher Stewart and the Company (BioNano Genomics, Inc, Filed With SEC on November 8, 2023)
- Consulting Agreement, dated August 3, 2023, between the Registrant and John Gerace (NanoString Technologies Inc, Filed With SEC on November 6, 2023)
- Form of Consulting Agreement between Atlantic International Corp. and Robert Machinist (SeqLL, Inc., Filed With SEC on August 15, 2023)
- Eliot M. Lurier Consulting Agreement, dated June 6, 2023, between SomaLogic, Inc. and Danforth (CM Life Sciences II Inc., Filed With SEC on August 14, 2023)
- Amendment No. 4 to Consulting Agreement, dated as of March 10, 2023, by and between 23andMe, Inc. and Richard Scheller, Ph.D (VG Acquisition Corp., Filed With SEC on May 25, 2023)
- Amendment No. 3 to Consulting Agreement, dated as of March 24, 2022, by and between 23andMe, Inc. and Richard Scheller, Ph.D (VG Acquisition Corp., Filed With SEC on May 25, 2023)
- Consulting Agreement between Jason Meggs and Syneos Health, Inc., dated January 5, 2023 (Syneos Health, Filed With SEC on January 9, 2023)
- Consulting Agreement by and between the Company and Matthew Weinstock dated October 4, 2022 (AbSci Corp, Filed With SEC on November 9, 2022)
- Deed of Amendment related to the Consulting Agreement and Settlement Agreement between Syneos Health UK Limited, Syneos Health, Inc. and Alistair Macdonald, dated June 29, 2022 (Syneos Health, Filed With SEC on August 2, 2022)
- Consulting Agreement between the Company and Alistair Macdonald, dated April 29, 2022 (Syneos Health, Filed With SEC on April 29, 2022)
- Consulting Agreement between the Registrant and Mark P. Stevenson, dated February 2 (Thermo Fisher Scientific, Filed With SEC on February 24, 2022)
- Consulting Agreement, dated as of August 12, 2021, by and between Quantum-Si Incorporated and Michael Mina, M.D., Ph.D (HighCape Capital Acquisition Corp., Filed With SEC on August 16, 2021)
- Transition and Consulting Agreement, dated April 19, 2021, between Waters Corporation and Ian S. King (Waters Corporation, Filed With SEC on May 6, 2021)
- Transition and Consulting Agreement, dated April 16, 2021, between Waters Corporation and Michael C. Harrington (Waters Corporation, Filed With SEC on May 6, 2021)
- Strategic/Scientific Advisor Consulting Agreement, dated as of April 1, 2017, by and between Berkeley Lights, Inc. and James Rothman, Ph.D., as amended (Berkeley Lights, Inc., Filed With SEC on June 26, 2020)
- Consulting Agreement, dated as of March 2, 2020, by and between Harvard Bioscience, Inc. and Chane Graziano (HARVARD BIOSCIENCE INC, Filed With SEC on March 6, 2020)
- Consulting Agreement Amendment, dated December 27, 2019, by and among Pharma-Bio Serv, Inc., Strategic Consultants International, LLC and Elizabeth Plaza, effective January 1, 2020 (Pharma-Bio Serv, Inc., Filed With SEC on December 27, 2019)
- Consulting Agreement (NEOGENOMICS INC, Filed With SEC on August 8, 2019)
- Consulting Agreement, effective August 2, 2019, by and between the Company and Jackson Streeter, M.D (Quanterix Corp, Filed With SEC on August 1, 2019)
- Consulting Agreement Amendment, dated December 31, 2018, by and among Pharma-Bio Serv, Inc., Strategic Consultants International, LLC and Elizabeth Plaza, effective January 1, 2019 (Pharma-Bio Serv, Inc., Filed With SEC on January 4, 2019)
- Consulting Agreement between Syneos Health, Inc. and Michael Bell effective December 10, 2018 (Syneos Health, Filed With SEC on December 10, 2018)
- Consulting Agreement with Standard Consulting LLC (ECO SCIENCE SOLUTIONS, INC., Filed With SEC on November 19, 2018)
- Consulting Agreement between Davide Molho and Charles River Laboratories, Inc. dated August 28, 2018 (Charles River Laboratories, Filed With SEC on November 7, 2018)
- Consulting Agreement Amendment, dated January 8, 2018, by and among Pharma-Bio Serv, Inc., Strategic Consultants International, LLC and Elizabeth Plaza, effective January 1, 2018 (Pharma-Bio Serv, Inc., Filed With SEC on January 8, 2018)
- AMENDMENT TO CONSULTING AGREEMENT (ECO SCIENCE SOLUTIONS, INC., Filed With SEC on October 6, 2017)
- CONSULTING AGREEMENT (ECO SCIENCE SOLUTIONS, INC., Filed With SEC on June 26, 2017)
- Agreement for Sale and Purchase of Business Assets of Green Style Consulting, LLC dated November 1, 2016 (EVIO, INC., Filed With SEC on February 24, 2017)
- Consulting Agreement Amendment, dated January 17, 2017, by and among Pharma-Bio Serv, Inc., Strategic Consultants International, LLC and Elizabeth Plaza, effective January 1, 2017 (Pharma-Bio Serv, Inc., Filed With SEC on January 20, 2017)
- Amended & Restated Consulting Agreement: Steven C. Jones (NEOGENOMICS INC, Filed With SEC on November 7, 2016)
- Consulting Agreement Amendment, dated December 30, 2015, by and among Pharma-Bio Serv, Inc., Strategic Consultants International, LLC and Elizabeth Plaza, effective January 1, 2016 (Pharma-Bio Serv, Inc., Filed With SEC on January 5, 2016)
- Consulting Agreement Amendment, effecctive as of July 1, 2015, by and among Pharma-Bio Serv, Inc., Strategic Consultants Interntational, LLC and Elizabeth Plaza (Pharma-Bio Serv, Inc., Filed With SEC on September 14, 2015)
- Consulting Agreement Amendment, dated January 1, 2015, by and among Pharma-Bio Serv, Inc., Strategic Consultants International, LLC and Elizabeth Plaza (Pharma-Bio Serv, Inc., Filed With SEC on January 5, 2015)
- CONSULTING AGREEMENT (Luminex Corporation, Filed With SEC on December 22, 2014)
- CONSULTING AGREEMENT (Luminex Corporation, Filed With SEC on October 20, 2014)
- CONSULTING AND GENERAL RELEASE AGREEMENT (IQVIA Holdings Inc., Filed With SEC on May 12, 2014)
- CODEXIS, INC. CONSULTING AGREEMENT (CODEXIS INC, Filed With SEC on March 13, 2014)
- Consulting Agreement, effective January 1, 2014, between Pharma-Bio Serv Inc., Strategic Consultants International, LLC and Elizabeth Plaza (Pharma-Bio Serv, Inc., Filed With SEC on December 31, 2013)
